Arefzadeh Alireza, Lessanpezeshki Mahboub, Seifi Sepideh
Department of Nephrology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Saudi J Kidney Dis Transpl. 2009 Mar;20(2):307-11.
The use of dialysis in patients with end-stage renal disease (ESRD) remains one of the most resource-intensive and hence, expensive therapeutic interventions. The purpose of this study was to assess the cost of hemodialysis (HD) in Iran. This study was conducted in the Department of Nephrology at the Imam Khomeini Hospital of Tehran University of Medical Sciences, Iran, between April 2006 and June 2007. Patients with ESRD on chronic HD were involved in the study. Relevant data were collected using interview and questionnaire. Analyzed costs included: transportation plus absence from work, treatment instruments, drugs and other medical procedures, diet, staff salary, equipment and building support services, non-medical supplies, depreciation of installations and equipments, depreciation of reverse osmosis (RO) and building rent. Sixty-three patients of whom 47.7% were males and 52.3% were females, with mean age of 47 +/- 12 years were studied. The estimated cost of each HD session was about 74 US dollars by which an annual cost of $11549 could be estimated for each patient. Transportation and work leaves (28.9%), staff costs and salaries (21.5%), and treatment instruments (21.1%) were among the greatest expenses. We conclude that the annual cost of dialysis in Iran is similar to other developing countries, but significantly less than the cost in developed countries.
在终末期肾病（ESRD）患者中使用透析仍然是资源消耗最大、因而也是最昂贵的治疗干预措施之一。本研究的目的是评估伊朗血液透析（HD）的成本。本研究于2006年4月至2007年6月在伊朗德黑兰医科大学伊玛目霍梅尼医院的肾病科进行。参与慢性血液透析的终末期肾病患者纳入本研究。通过访谈和问卷收集相关数据。分析的成本包括：交通及误工费用、治疗器械、药物及其他医疗程序、饮食、工作人员工资、设备及建筑支持服务、非医疗用品、设施和设备折旧、反渗透（RO）折旧及房租。研究了63例患者，其中男性占47.7%，女性占52.3%，平均年龄为47±12岁。每次血液透析治疗的估计成本约为74美元，据此估计每位患者每年的成本为11549美元。交通及误工费用（28.9%）、工作人员成本及工资（21.5%）和治疗器械（21.1%）是最大的开支项目。我们得出结论，伊朗透析的年度成本与其他发展中国家相似，但显著低于发达国家的成本。
